Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Pharmaceutical industry news

Show

From To
CHMP Recommends for Approval Generic Version of Truvada

At its September meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended for approval a generic version of Truvada – Emtricitabine/Tenofovir disoproxil Zentiva (emtricitabine/tenofovir disoproxil) for the treatment of HIV infection.

Published
20 September 2016
From
EATG
Behind Battle Over Drug Prices, Quiet Money From Big Pharma

Is there a conflict of interest for hepatitis C advocates in accepting funds from pharmaceutical companies and representing the interests of patients when questions of drug pricing and access to treatment are being debated?

Published
19 September 2016
From
Bloomberg
Janssen Submits Marketing Authorisation Application for Darunavir-Based Single Tablet Regimen for Treatment of HIV-1 to European Medicines Agency

If approved, this tablet would be the first protease inhibitor-based STR option indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 infection in adults and adolescents. This new treatment would combine the protease inhibitor, darunavir (DRV, D, 800 mg), with the pharmacokinetic enhancer, cobicistat (COBI, C, 150 mg) and the nucleoside reverse transcriptase inhibitors emtricitabine (FTC, F, 200 mg) and tenofovir alafenamide (TAF 10 mg), in one single tablet.

Published
13 September 2016
From
Janssen-Cilag press release
ContraVir Reports New CRV431 Data Highlighting Synergistic Activity with CMX157 Against Hepatitis B

ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today announced that it has taken a major step forward in its pursuit of a potentially curative combination therapy for chronic hepatitis B (HBV).

Published
12 September 2016
From
ContraVir press release
Drug firm boss who raised price of HIV medicine trolls Hillary Clinton after collapse at 9/11 memorial service

A 'hated' drug firm boss who raised the price of HIV medicine recorded a video of himself trolling Hillary Clinton after she collapsed at a 9/11 memorial service. Martin Shkreli shouted abuse at the politician as she left her daughter's apartment where she had been resting after suffering from pneumonia

Published
12 September 2016
From
Mirror.co.uk
WHO launches Target Regimen Profiles for TB treatment

Aimed at the pharmaceutical industry, research institutions, product development partnerships and donors, the new profiles seek to guide the drug/regimen development process, enabling important drug and regimen features to respond to the needs of end-users, care providers and policymakers.

Published
08 September 2016
From
World Health Organization
Letter to Gilead Sciences on attempts to remove generic sofosbuvir from Ukraine

MSF is in the process of planning and beginning to deliver hepatitis C treatment to patients in Ukraine, a country suffering from the highest hepatitis C prevalence in the region - and which has one of the world’s highest rates of hepatitis C infection. The availability of multiple sources of new DAAs - and, in particular, sofosbuvir - is critical for treatment providers, including MSF, to manage a sustainable and affordable supply for medical operations.

Published
07 September 2016
From
MSF
Doctors Without Borders urges Gilead to rethink its hepatitis C strategy in Ukraine

The latest battle over access to medicines is taking place in Ukraine, where Doctors Without Borders is urging Gilead Sciences to drop a court action that, if successful, would prevent a generic version of the Sovaldi hepatitis C treatment from ...

Published
07 September 2016
From
STAT
Ukraine's medicine bill slashed by 25% after UK firm brought in to handle procurement

Crown Agents and two UN agencies are working to root out corrupt intermediaries but are facing politcal resistance to change.

Published
01 September 2016
From
The Guardian
University of Minnesota sues Gilead Sciences over hepatitis drugs

In a lawsuit filed Monday, the University of Minnesota alleges that California-based Gilead Sciences has infringed, and continues to infringe, on the university’s intellectual property rights by selling three medicines that contain the drug sofosbuvir.

Published
31 August 2016
From
Minneapolis Star Tribune
← First12345...90Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close